Epigenetics is the study of changes in gene activity that do not involve alterations to the underlying DNA sequence. In simpler terms: your genes are not a fixed destiny. The way they are read, expressed, and passed on is shaped by your environment, your experiences, your diet, your stress levels, and even events that happened to your parents and grandparents before you were born.
That last point is the one that surprised science most. For most of the twentieth century, the dominant view in genetics was that acquired characteristics could not be inherited — that what happened to you in your lifetime had no effect on the genes you passed to your children. Epigenetics has complicated that view significantly. According to research published in ACS Pharmacology and Translational Science in 2026, environmental epigenetic research now demonstrates how external factors induce heritable epigenetic changes with implications for health across multiple generations.
This article explains how epigenetics works, what the most important recent discoveries have revealed, and why this field is quietly transforming medicine in ways that may affect every one of us.
How Epigenetics Works: The Basics
Every cell in your body contains the same DNA — the same sequence of approximately three billion base pairs that encodes your complete genetic information. Yet a liver cell looks and behaves completely differently from a neuron, a skin cell, or a muscle cell. The reason is not a difference in the DNA itself. It is a difference in which genes are switched on and which are switched off.
Epigenetics is the system that controls this switching. It operates through chemical tags and structural modifications that attach to DNA and to the proteins around which DNA is wrapped — collectively deciding which genes are accessible to be read and which are silenced. These modifications do not change the sequence of the genetic code. They change whether and how that code is expressed.
The word epigenetics comes from the Greek prefix epi, meaning above or upon. Epigenetic changes sit above the genome — they are a layer of regulation that operates on top of the genetic code, responding to signals from inside and outside the cell.
What makes this scientifically significant — and personally relevant — is that these modifications are not random. They are responsive. Studies show that what you eat, how much you exercise, the stress you experience, the toxins you are exposed to, and even the emotional environment of your early childhood can all leave measurable epigenetic marks on your genome. Some of these marks persist for decades. Some appear to be transmitted to the next generation.
The Dutch Hunger Winter: The Discovery That Changed Everything
The most compelling early evidence that epigenetic effects can cross generations came from one of the darkest episodes of the Second World War. In the winter of 1944 to 1945, a German blockade cut off food supplies to the western Netherlands. For approximately five months, the civilian population survived on as few as 400 to 800 calories per day — roughly a quarter of normal intake. An estimated 18,000 people died of starvation before the liberation in May 1945.
Decades later, researchers studied the children born to women who had been pregnant during the famine. The findings were striking. According to research published in peer-reviewed literature, individuals who had been in the womb during the famine showed significantly higher rates of obesity, diabetes, cardiovascular disease, and mental health conditions compared to siblings conceived before or after the famine — despite having the same genetic background.
More significantly, some of these effects appeared in the grandchildren of the famine survivors. The epigenetic marks left by extreme malnutrition during a critical developmental window had been transmitted across at least one generation, influencing health outcomes in people who had never themselves experienced the famine.
This was not the inheritance of genetic mutations. The DNA sequence of the children and grandchildren was unchanged. What had changed was the epigenetic instruction set sitting on top of it — the chemical annotations that determined how certain genes were expressed. The Dutch Hunger Winter became one of the most studied examples of transgenerational epigenetic inheritance in humans.
The Three Main Mechanisms: Methylation, Histones, and RNA
DNA Methylation
The most studied epigenetic mechanism is DNA methylation — the addition of a small chemical group called a methyl group to specific locations on the DNA strand, most often at sites where cytosine and guanine bases occur together. According to research from the National Institutes of Health, methylation at gene promoter regions typically silences gene expression — it acts as a molecular lock that prevents the gene from being read.
Methylation patterns are established during development and maintained through cell division — when a cell divides, the methylation pattern is copied to the new cell. But they are also dynamic: environmental factors can add or remove methyl groups, changing which genes are active. This dynamism is both the promise and the complexity of epigenetics.
Histone Modification
DNA does not float freely in the cell nucleus. It is tightly wound around proteins called histones — spools around which the DNA double helix coils. The way DNA is wound around histones determines its accessibility. Tightly wound DNA cannot be read; loosely wound DNA can.
Chemical modifications to histone proteins — acetylation, methylation, phosphorylation, and others — alter how tightly DNA is wound, effectively opening or closing sections of the genome to transcription. Scientists have observed that histone modifications respond rapidly to environmental signals and can regulate large sections of the genome simultaneously, making them powerful epigenetic switches.
Non-Coding RNA
A third mechanism involves RNA molecules that do not code for proteins — so-called non-coding RNAs — which regulate gene expression by targeting specific messenger RNA molecules for degradation or by blocking their translation into protein. According to research from the University at Albany published in February 2026, scientists are now embarking on what they describe as the RNA equivalent of the Human Genome Project — a systematic effort to sequence and map all the chemical modifications present in human RNA. This work, known as the epitranscriptome, represents a new frontier in understanding how gene expression is regulated at the molecular level.
What Scientists Discovered in 2025 and 2026
Epigenetics research has accelerated rapidly in the past eighteen months, driven by new tools that allow scientists to map the epigenome at single-cell resolution and in real time.
In January 2026, researchers reported a significant CRISPR breakthrough: scientists can now turn genes back on without cutting DNA, by removing the chemical tags — specifically methyl groups — that had silenced them. According to ScienceDaily, the work confirmed that these tags actively silence genes, settling a long-running scientific debate about the causal role of methylation in gene silencing. This matters enormously for medicine: if silenced genes can be reactivated precisely, without cutting DNA, it opens a path to treating diseases caused by inappropriately silenced genes — including certain cancers — with significantly lower risk than conventional gene editing.
Also in January 2026, researchers published the most detailed map ever made of the three-dimensional architecture of the genome — showing how DNA folds, loops, and rearranges itself inside cells, and how this structure changes from one cell type to another. According to the research, this hidden architecture plays a central role in regulating which genes are expressed, adding a spatial dimension to epigenetic control that had been poorly understood.
In December 2025, a study published through ScienceDaily showed that maternal epigenetic marks transmitted through the egg yolk regulate gene expression in embryos — linking the mother’s environment to the regulatory information inherited by her offspring. This finding, in animal models, provides a molecular mechanism for transgenerational epigenetic inheritance and has direct implications for understanding how parental experiences affect offspring health.
How Epigenetics Is Changing Medicine Right Now
Epigenetics is no longer purely academic. According to a 2026 review published in ACS Pharmacology and Translational Science, more than 50 clinical trials are currently investigating epigenetic drugs — compounds designed to modify the epigenome to treat disease.
In cancer medicine, two epigenetic drugs received regulatory approval in the period between 2024 and 2025. Revuforj (revumenib) gained U.S. FDA approval in November 2024 for relapsed or refractory acute myeloid leukaemia with a specific genetic rearrangement. Modeyso (dordaviprone) received U.S. FDA accelerated approval in August 2025 for a type of aggressive brain tumour — H3K27M-mutant diffuse midline gliomas — targeting the specific histone mutation that drives the cancer’s growth. Both approvals represent a shift toward treating the epigenetic dysregulation underlying cancer rather than simply targeting the cancer cells themselves.
Beyond cancer, clinical trials are investigating epigenetic treatments for conditions as varied as alcoholic hepatitis, borderline personality disorder, myelofibrosis, and diabetic neuropathy. This diversification reflects a growing understanding that epigenetic dysregulation is not a cancer-specific phenomenon — it is a feature of many chronic conditions that have previously resisted conventional treatment.
The connection to our own article on gene editing in 2026 is direct: where conventional CRISPR cuts the DNA sequence, epigenetic CRISPR approaches modify how genes are expressed without making permanent changes to the code itself — a safer, more reversible approach for many therapeutic applications.
Epigenetics and Aging: Reading the Clock in Your Cells

One of the most remarkable applications of epigenetics is the development of biological age clocks. Studies have shown that methylation patterns across specific sites in the genome change predictably with age — so predictably that researchers can calculate a person’s biological age from a blood or tissue sample with considerable accuracy.
The most well-known of these is the Horvath clock, developed by UCLA professor Steve Horvath in 2013 and refined repeatedly since. According to research using this tool, biological age — as measured by methylation patterns — is a better predictor of health outcomes and lifespan than chronological age. Two people who are both 50 years old may have significantly different biological ages, and the difference matters for their disease risk and their prospects for healthy ageing.
This has opened a new front in longevity research. If the epigenetic clock can be read accurately, it can also potentially be reset — returned to a younger state through interventions that reverse age-related methylation changes. According to research from the field of epigenetic reprogramming, partial reprogramming of aged cells using molecular factors can restore youthful gene expression patterns without erasing the cell’s identity. This work, still in animal models and early human studies, represents one of the most actively pursued directions in the science of ageing.
Legacy: Why Epigenetics Changes How We Think About Inheritance
The classical picture of genetics — fixed sequences of DNA, passed from parents to children, determining biological traits — is not wrong. But epigenetics has revealed that it is incomplete.
What you inherit from your parents is not just a DNA sequence. It is a DNA sequence with an epigenetic instruction set — a layer of chemical annotations shaped by your parents’ experiences, environment, and health — that influences how those genes are expressed in your developing body. This does not mean your destiny is written by your parents’ lives. Epigenetic marks are dynamic and many are reversible. But it does mean that the story of inheritance is significantly more complex than the simple transmission of a fixed genetic code.
The question of how much epigenetic information crosses the generational barrier — and through what mechanisms — is one of the most actively researched questions in modern genetics. Work on non-coding DNA and its regulatory functions is directly relevant here, as many epigenetic regulators operate through the non-coding regions of the genome that were once dismissed as genetic noise.
The practical implications extend to medicine, public health, and our understanding of how social and environmental conditions affect health across generations. If poverty, trauma, and toxic stress leave epigenetic marks that are transmitted to children, then the health consequences of social inequality are not simply behavioural or nutritional — they are molecular. That changes how we should think about intervention, prevention, and the long-term costs of failing to address adverse conditions early in life.
What Scientists Say
According to a 2026 review in ACS Pharmacology and Translational Science, epigenetics has emerged as “a transformative field in biology and medicine, revealing how gene expression is modulated in response to internal and external cues” and is now “a cornerstone of modern biomedical research.”
Thomas Begley and Marlene Belfort of the University at Albany, writing in The Conversation in February 2026, described the emerging field of epitranscriptomics — the mapping of chemical modifications on RNA — as a project of comparable scope to the original Human Genome Project. “We are just beginning to appreciate how much information is encoded not in the DNA sequence itself,” they wrote, “but in the chemical modifications that sit on top of it.”
Scientists have observed that the pace of discovery in epigenetics has accelerated sharply since the development of single-cell epigenomic sequencing — a technology that allows researchers to map the epigenetic state of individual cells within a tissue, rather than averaging across millions of cells as earlier methods required. According to a review published in Epigenomics in November 2025, this methodological breakthrough has “transformed epigenomics from bulk, population-averaged assays into single-cell, multi-omic investigations,” revealing a level of cellular diversity that was previously invisible.
Frequently Asked Questions
What is the difference between genetics and epigenetics?
Genetics is the study of the DNA sequence itself — the inherited code that encodes proteins and biological traits. Epigenetics is the study of how that code is regulated — which genes are switched on or off, and how that regulation changes in response to environment and experience. Genetic changes alter the DNA sequence. Epigenetic changes alter gene expression without changing the sequence. Both contribute to who we are and how we age.
Can epigenetic changes be reversed?
Yes, in many cases. Unlike genetic mutations, epigenetic modifications are dynamic and potentially reversible. Lifestyle factors — diet, exercise, stress reduction — can influence methylation patterns. Several epigenetic drugs approved by the FDA work precisely by reversing the epigenetic modifications that drive cancer growth. Emerging research on epigenetic reprogramming suggests that age-related epigenetic changes may also be partially reversible, though this remains an active and not yet clinically established area of research.
Do epigenetic changes get passed to children?
Some do. The Dutch Hunger Winter studies and other research provide strong evidence that certain epigenetic marks can be transmitted across at least one generation — meaning that environmental exposures experienced by parents can influence the gene expression patterns of their children. The precise mechanisms by which epigenetic information crosses the generational barrier are still being investigated, and the extent of transgenerational epigenetic inheritance in humans remains an active area of debate and research.
How does stress affect the epigenome?
Studies show that chronic psychological stress — particularly in early childhood — produces measurable epigenetic changes, particularly in genes related to the stress response system, immune function, and inflammation. Research on adverse childhood experiences has found that individuals exposed to significant early-life stress show distinctive methylation patterns that persist into adulthood and are associated with increased risk of mental health conditions, cardiovascular disease, and other chronic conditions. These findings do not mean that early stress creates permanent damage — many epigenetic changes are reversible — but they provide a molecular mechanism linking social experience to biological health outcomes.
What are epigenetic drugs and how do they work?
Epigenetic drugs are compounds that modify specific epigenetic mechanisms — inhibiting enzymes that add or remove methyl groups, altering histone modifications, or interfering with non-coding RNA function — to change gene expression patterns in diseased cells. Unlike conventional chemotherapy, which typically kills cells, epigenetic drugs aim to reprogram them — restoring normal gene expression patterns in cancer cells or other cells with abnormal epigenetic states. More than 50 epigenetic drugs are currently in clinical trials, targeting conditions from leukaemia and brain tumours to alcoholic hepatitis and personality disorders.
Further Reading
Recommended Reading
- Nature — Epigenetics Research Hub — The most authoritative source for peer-reviewed epigenetics research, updated continuously
- CAS — The Future of Epigenetics: Emerging Technologies and Clinical Applications — Comprehensive 2026 review of epigenetic technologies and clinical trials
- The Epigenetics Revolution by Nessa Carey — The clearest and most accessible book-length introduction to epigenetics for general readers
- Epigenetics: How Environment Shapes Our Genes by Richard Francis — A compelling account of how life experiences leave molecular marks on DNA
Sources
- PMC / ACS Pharmacology and Translational Science (2026) — The Future of Epigenetics: Emerging Technologies and Clinical Applications
- CAS (January 2026) — The Future of Epigenetics: Emerging Technologies and Clinical Applications
- Nature — Epigenetics Research (Updated May 27, 2026)
- ScienceDaily — Epigenetics News (January 2026)
- The Conversation — Epigenetics Research and Analysis
- Epigenomics (November 2025) — Recent Advances in Methodologies of Epigenomics
- Wikipedia — Epigenetics
- Wikipedia — Dutch Famine of 1944–1945
About the Author
Baryon is the founder and editor of Web News For Us. Driven by a deep fascination with the biggest unanswered questions in science — from the arrow of time and the nature of consciousness to the genetic code of life and the possibility of parallel universes — he has spent years studying modern science, cosmology and the history of scientific thought.
He covers Science and AI, Space, Genetics and Research, along with the timeless wisdom of history’s greatest thinkers and mystics.
If you have ever looked at the night sky and felt that pull to understand what is out there, you are in the right place.
Discover more from Web News For Us
Subscribe to get the latest posts sent to your email.
